Systemic lupus erythematosus (SLE) is complicated from both
Systemic lupus erythematosus (SLE) is a clinically complicated disease of unknown origin. As evidenced by the classification criteria, the manifestations of SLE vary widely among individuals with the disease. 1, 2 Epidemiological studies of families and twins have indicated a substantial genetic predisposition to SLE. 3, 4 Recently, genome-wide scans have found over a dozen chromosomal intervals linked to the SLE phenotype in families in which more than one individual has SLE. [5] [6] [7] [8] [9] We have hypothesized that the use of the clinical variation found among patients with SLE can be used in studies of the genetics of the disease, and this approach has proved useful so far. 10 Thrombocytopenia is a manifestation of SLE that is of particular clinical interest because of its strong association with mortality. 11 Low platelet count is part of the diagnostic criteria for SLE 1 and occurs in 10-20% of SLE patients. We have stratified families multiplex for SLE on the basis of the presence of thrombocytopenia in at least one SLE patient in an effort to achieve a more homogeneous set of families for genetic study. This study demonstrates that these families have a severe form of SLE, even among SLE patients without thrombocytopenia in these families, regardless of race. Furthermore, we identified a genetic linkage effect in African-American SLE families with thrombocytopenia at chromosome 11p13 with a LOD score of 5.72 (Scofield RH, Bruner GR, Kelly JA, Kilpatrick J, Bacino D, Nath SK, Harley JB. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q21 and 11p13, manuscript submitted).
In the present study, we have investigated CD44 as a candidate gene. The CD44 gene lies only 0.5 cM from the peak LOD score found at marker D11s1392. CD44 is a cell surface glycoprotein that is a major receptor for hyaluronan. The molecule is involved in cell adhesion and is expressed on immune cells such as lymphocytes and leukocytes as well as a wide variety of other cells.
12 CD44 is implicated in the pathogenesis of several inflammatory illnesses and its interaction with hyaluronan is considered a potential therapeutic target in inflammatory diseases. 12 The CD44 protein is polymorphic on the basis of isoforms resulting from alternative splicing. Some isoforms are expressed in a tissue or cell specific manner. 13 Thus, we hypothesized that CD44 was an important candidate within the linkage interval defined on chromosome 11p13 among African-American SLE families with thrombocytopenia.
Families were recruited, screened and interviewed as previously described. 5 All patients met the American College of Rheumatology (ACR) criteria for the classification of systemic lupus.
1,2 Typing of short repeat microsatellite markers was performed as previously described. 5 Throm-bocytopenia was determined by review of all available medical records, patients interview and questionnaire as well as interview of treating physicians. A platelet count of less than 100 000/mm 3 was considered significant. This is the definition used by the ACR criteria. 1 Six short tandem repeating DNA segments within the CD44 gene were identified ( Table 1) . Three of these markers were found to be polymorphic. There were 13 African-American families useful for linkage in which at least one SLE patient had thrombocytopenia. These families were previously studied to establish linkage at 11p13 (Scofield et al, manuscript submitted). A total of 78 individuals were included in these pedigrees, all of whom were studied with the three polymorphic short tandem repeat markers. We found a maximum two-point LOD score of 2.721 for one of the markers in these 13 families with a dominant inheritance pattern ( Table 2 ). In this model, penetrance values varied between men and women (49% and 92%, respectively). This LOD score, then, confirms linkage for this chromosomal region to SLE in African-American families where SLE is manifested by thrombocytopenia since the result exceeds the level required for conformation (P Ͻ 0.01). The other two tandem repeats within the CD44 gene did not have significant LOD scores, but the informativity of these markers was low.
In order to assess the possibility that CD44 was in fact the gene responsible for the observed linkage, we studied the linkage and association of single nucleotide polymorphisms (SNPs) lying within the CD44 gene to SLE in this population. We found four informative SNPs within the CD44 gene (Table 2 ). There was no linkage to the SLE phenotype for any of these SNPs in the 13 AfricanAmerican families with thrombocytopenia when studied by maximum-likelihood model-based linkage analysis, or by affected sibling pair analysis. In addition, when performing the transmission disequilibrium test, we found no transmission distortion of any allele within the four SNPs (Table 3) . CD44 haplotypes were generated with these four SNPs from GENEHUNTER-PLUS. Expected and observed counts of transmitted and non-transmitted alleles were evaluated using: (1) trios and, (2) 15 Six tandem repeats that had a period size of 2, 3 or 4, a copy number greater than 10 and a percent match greater than 90% were found either within or near the CD44 gene with three of these regions polymorphic (see above). The 78 participants DNA samples were genotyped by polymerase chain reaction and separated the PCR products by size as described elsewhere 5, 10 at the three polymorphic tandem repeat markers. One of the tandem repeat markers located near the middle of the gene showed linkage to lupus with a LOD score of 2.721 and is shown above. For the polymorphic markers (1, 5 and 6 in Table 1 ), primers to unique sequences were designed that flanked tandem repeats. PCR was performed as previously described, 5 using the following primers: repeat 1: Forward 5′ CTCTTTCTACTAGTGGC TTTGTA 3′/reverse 5′ GAGCATGAGAGGCTTCCTTT 3′, repeat 5: Forward 5′ GGGCTGCAAGGGATTTTCAA 3′/reverse 5′ GGTT ACTAGAGACCTTGAAG 3′, repeat 6: Forward 5′ GATAGAGACAA TTAAGAGATAGAG 3′/reverse 5′ TGGATGCATCCTGTGAGTTC 3′. Each of the forward primers also contained an M13-29 primer tail (5′ CACGACGTTGTAAAACGAC 3′). Maximum-likelihood modelbased linkage analysis was performed as previously described using a screening set of six models. The maximum LOD score was obtained under an autosomal dominant model with a mixed penetrance (dom mix) in which the penetrance in men is 49% and that of women is 92%. 5, 14 found to be in linkage disequilibrium (data not presented).
Genes and Immunity
We have stratified SLE families by the presence of thrombocytopenia in at least one SLE patient. This manifestation of SLE is strongly associated with an increased mortality. 10, 12 In our families with SLE, the presence of thrombocytopenia in one member of a family is associated with severe disease in other members of the family, despite the fact that these other SLE affected members do not tend to have thrombocytopenia (Scofield et al, submitted) Thus, thrombocytopenia identifies not just individual patients, but entire families with severe SLE. Therefore, our effort in which SLE families are stratified by thrombocytopenia is likely to identify genes associated with severe disease. Identification of such genes will undoubtably prove useful to understand the disease itself and in developing new therapeutic strategies.
There are, of course, potential problems associated with our approach in which a small portion of the families are examined. This may lead to false positive results. However, we have now confirmed our initial results with the microsatellite marker within the CD44 gene. In addition, we have identified a number of other microsatellites in this region but not within CD44 that also confirm linkage (not shown). Finally, we have performed simulation studies by randomly selecting 13 AfricanAmerican pedigrees from the 63 total families of subSaharan origin. These simulations indicate that the results obtained are highly statistically significant (unpublished data, manuscript in preparation). Four of the 10 SNPs were found to actually be polymorphic and informative, and are shown above. The oligonucleotide primers were as follows-for dbSNP 932633 through 932635 forward primer 5′ GCCTGTGAGGAGCATATAGC 3′/reverse primer 5′ GTCATCTCCTTCATCCTGT 3′. For dbSNP 1467558 forward primer 5′ GTGGCTGAGCATCGTTATTC 3′/reverse primer 5′ TTTCCTCTTGGCCAGATGTG 3′. Each forward primer contained an M13 −20 tail (5′ TTGTAAAACGACGGCCAGT 3′) and each reverse primer contained an M13 reverse primer tail (5′ GGATAACAATTTCACACAGG 3′). PCR reactions were performed under standard conditions as described. 5 PCR products were directly sequenced in order to determine the allele in each of the 78 individuals in the 13 African-American families with SLE manifested by thrombocytopenia.
CD44 is within 1 cM of the peak LOD score previously found (Scofield et al, submitted) Further, this gene is of interest because of its multiple functions, including its apparent role in inflammation. The CD44 protein is polymorphic based on extensive alternative splicing that produces tissue specific alternative proteins. The CD44 gene is large. Our data with the SNPs within CD44 strongly suggest that an ancient, ancestral CD44 allele is not the actual gene producing the observed linkage. However, association operates over a short genetic interval, so these data do not eliminate the possibility that CD44 is important to SLE linkage in this chromosomal region. The small number of families studied and the informativity of the SNP markers limit the power of the TDT test to detect association. A series of SNPs each in linkage disequilibrium with its closest neighbors that do not show genetic association and can be studied as extended haplotypes will be needed to eliminate CD44 as a candidate gene.
Nonetheless, these data suggest that CD44 is not the gene responsible for the linkage observed. This result means that our attention will be drawn to other interesting genes within the linkage interval, such as CD59. In the near future we hope to be in the position to confirm or refute linkage in a new cohort of African-American families with SLE manifested by thrombocytopenia. We have a new cohort collection assembled that is equal in size to the population previously studied. When typing at a set of genome-wide markers and clinical assessment is complete, we can begin analyses. If confirmed, we will then be confident that a gene, likely associated with severe lupus, but not CD44, is present within the linkage interval at chromosome 11p13.
